InGeneron

develops and commercializes stem cell-based regenerative medicine therapies for the treatment of orthopedic, esthetics​ and wound care...
Read more
InGeneron CEO: Angelo Moesslang

CEO

Angelo Moesslang

CEO Approval Rating

83/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$53.3M

InGeneron Competitors

1Osiris Therapeutics
2Cesca
3Caladrius
4Alliqua
5Reapplix
6Amniotechnology
7Mesoblast
8Asterias Biotherapeutics, Inc.
9Capricor
10Surrozen

Trending Companies